Paragon 28 Inc FNA

Morningstar Rating
$5.83 −0.10 (1.69%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FNA is trading at a 357% premium.
Price
$5.93
Fair Value
$2.82
Uncertainty
Very High
1-Star Price
$68.66
5-Star Price
$4.23
Economic Moat
Pzn
Capital Allocation

News

Trading Information

Previous Close Price
$5.93
Day Range
$5.805.92
52-Week Range
$5.5914.78
Bid/Ask
$5.82 / $5.84
Market Cap
$487.05 Mil
Volume/Avg
53,078 / 555,841

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.09
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
574

Comparables

Valuation

Metric
FNA
TMCI
688016
Price/Earnings (Normalized)
22.39
Price/Book Value
3.383.023.46
Price/Sales
2.091.709.68
Price/Cash Flow
19.38
Price/Earnings
FNA
TMCI
688016

Financial Strength

Metric
FNA
TMCI
688016
Quick Ratio
1.632.718.91
Current Ratio
3.573.869.53
Interest Coverage
−6.86−12.36413.50
Quick Ratio
FNA
TMCI
688016

Profitability

Metric
FNA
TMCI
688016
Return on Assets (Normalized)
−17.60%−15.89%16.12%
Return on Equity (Normalized)
−31.66%−28.96%18.19%
Return on Invested Capital (Normalized)
−18.77%−19.43%17.54%
Return on Assets
FNA
TMCI
688016

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
KtfzdjddtCqvlrp$197.7 Bil
Stryker Corp
SYK
YrksxbmzqTczg$135.3 Bil
Boston Scientific Corp
BSX
CshjbgsmSmhtrn$124.4 Bil
Medtronic PLC
MDT
RvjgtpdfPhcmww$114.3 Bil
Edwards Lifesciences Corp
EW
DlzpdzfxtZmsyg$39.2 Bil
Koninklijke Philips NV ADR
PHG
SnhdkQkn$30.2 Bil
DexCom Inc
DXCM
DwfdjqslmXtrg$26.9 Bil
Steris PLC
STE
LgkfctgfLpmcg$23.1 Bil
Zimmer Biomet Holdings Inc
ZBH
ZbzbdjgsrkNvb$21.5 Bil
Insulet Corp
PODD
FzrlbrqxpMhbth$16.3 Bil

Sponsor Center